The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 93-97

  Fathi, Ali R ^a,b   Bakhtian, Kamran D ^a   Pluta, Ryszard M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Cerebral vasospasm; DIND; Nitric oxide; NO Donors; Subarachnoid hemorrhage

Indexed keywords

DIAZENIUMDIOLATE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; HYDROXYLAMINE; LINSIDOMINE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; S NITROSOGLUTATHIONE; S NITROSOTHIOL; SODIUM NITRITE; UNCLASSIFIED DRUG;

ANGINA PECTORIS; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN VASOSPASM; CONFERENCE PAPER; CYANIDE POISONING; DRUG ACTIVITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERANCE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; INTRACRANIAL PRESSURE; MEAN ARTERIAL PRESSURE; MIGRAINE; NAUSEA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRESSURE; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER; VASODILATATION; VOMITING;

EID: 85052609971     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0353-1_17     Document Type: Conference Paper

References (41)

1. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al. Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol Res. 2009;31:151-58.
2. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: The emerging revolution. Nat Clin Pract Neurol. 2007;3:256-63.
3. Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurol Res. 2006;28:730-37.
4. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971-82.
5. Allen GS, Gross CJ. Cerebral arterial spasm. Part 7: In vitro effects of alpha adrenergic agents on canine arteries from six anatomical sites and six blocking agents on serotonin-induced contractions of the canine basilar artery. Surg Neurol. 1976;6:63-70.
6. Allen GS. Cerebral arterial spasm. Part 8: The treatment of delayed cerebral arterial spasm in human beings. Surg Neurol. 1976;6: 71-80.
7. Egemen N, Turker RK, Sanlidilek U, Zorlutuna A, Bilgic S, Baskaya M, et al. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res. 1993;15:310-15.
8. Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 2002;50:1006-13; discussion 1013-1004.
9. Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 1999;30:1409-16.
10. Ram Z, Spiegelman R, Findler G, Hadani M. Delayed postoperative neurological deterioration from prolonged sodium nitroprusside administration. Case report. J Neurosurg. 1989;71:605-7.
11. Nakao K, Murata H, Kanamaru K, Waga S. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage. Stroke 1996;27:1882-87; discussion 1887-1888.
12. Reinert M, Wiest R, Barth L, Andres R, Ozdoba C, Seiler R. Transdermal nitroglycerin in patients with subarachnoid hemorrhage. Neurol Res. 2004;26:435-39.
13. Tanaka Y, Masuzawa T, Saito M, Yamada T, Ebihara A, Iwasa H, et al. Combined administration of Fasudil hydrochloride and nitroglycerin for treatment of cerebral vasospasm. Acta Neurochir Suppl. 2001;77:205-7.
14. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med. 2008;34:932-38.
15. Keefer LK. Progress toward clinical application of the nitric oxidereleasing diazeniumdiolates. Annu Rev Pharmacol Toxicol. 2003; 43:585-607.
16. Aihara Y, Jahromi BS, Yassari R, Sayama T, Macdonald RL. Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Neurosurgery 2003;52:661-7; discussion 666-667.
17. Clatterbuck RE, Gailloud P, Tierney T, Clatterbuck VM, Murphy KJ, Tamargo RJ. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg. 2005;103:745-51.
18. Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg. 1997;87:746-51.
19. Sehba FA, Friedrich V, Jr., Makonnen G, Bederson JB. Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg. 2007;106:321-29.
20. Sehba FA, Ding WH, Chereshnev I, Bederson JB. Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage. Stroke 1999;30:1955-61.
21. Kiris T, Karasu A, Yavuz C, Erdem T, Unal F, Hepgul K, et al. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141:1323-28; discussion 1328-1329.
22. Furchgott RF, Bhadrakom S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther. 1953;108:129-43.
23. Toda N. The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog. J Pharmacol Exp Ther. 1974;191:139-46.
24. Sonobe M, Suzuki J. Vasospasmogenic substance produced following subarachnoid hemorrhage, and its fate. Neurol Med-Chir. 1978;18 II:29-37.
25. Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 2005;293:1477-84.
26. Fathi A.R., Pluta R.M., Qi M., Bakhtian K.D., Lonser R.R. 2009. Short-lasting Intravenous Sodium Nitrite Ameliorates Cerebral Vasospasm In A Primate Model Of SAH, 10th International Conference On Cerebral Vasospasm Chongqing China
27. Fathi AR, Pluta RM, Qi M, Bakhtian KD, Lonser RR. Short-lasting intravenous sodium nitrite ameliorates cerebral vasospasm in a primate model of SAH. The 10th International Conference on Cerebral Vasospasm Chongqing, China; 2009. 27. Soderberg LS. Increased tumor growth in mice exposed to inhaled isobutyl nitrite. Toxicol Lett. 1999104:35-41.
28. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: The physiologic context for potential health benefits. Am J Clin Nutr. 2009;90:1-10.
29. Hunault CC, van Velzen AG, Sips AJ, Schothorst RC, Meulenbelt J. Bioavailability of sodium nitrite from an aqueous solution in healthy adults. Toxicol Lett. 2009;190:48-53.
30. Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1995;83:118-22.
31. Islam MS, Ohkuma H, Kimura M, Suzuki S. In vitro effects of new generation fungal derived nitric oxide donors on rabbit basilar artery. Neurol Med Chir (Tokyo). 2003;43:175-80; discussion 180.
32. Ryba MS, Gordon-Krajcer W, Walski M, Chalimoniuk M, Chrapusta SJ. Hydroxylamine attenuates the effects of simulated subarachnoid hemorrhage in the rat brain and improves neurological outcome. Brain Res. 1999;850:225-33.
33. Yamamoto S, Nishizawa S, Yokoyama T, Ryu H, Uemura K. Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries. Brain Res. 1997;757:1-9.
34. Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM. Association between cerebrospinal fluid levels of asymmetric dimethyl-l-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg. 2004;101:836-42.
35. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007;42:271-79.
36. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J Pharmacol Exp Ther. 2001;299:818-24.
37. Fathi AR, Zhuang Z, Xia J, Lu J, Merrill M, Cleary S, et al. Inhibition of protein phosphatase 2A stimulates endothelial nitric oxide synthase in human umbilical vein endothelial and renal carcinoma cell line The 10th International Conference on Cerebral Vasospasm Chongqing, China; 2009.
38. Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: A Phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg. 2009;111:171-80.
39. Grasso G, Passalacqua M, Sfacteria A, Conti A, Morabito A, Mazzullo G, et al. Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? J Neurosurg. 2002;96:565-70.
40. Santhanam AV, Katusic ZS. Erythropoietin and cerebral vascular protection: Role of nitric oxide. Acta Pharmacol Sin. 2006;27: 1389-94.
41. Onoue H, Tsutsui M, Smith L, Stelter A, O'Brien T, Katusic ZS. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 1998;29:1959-65; discussion 1965-1956.